Share on LinkedInShare on LinkedIn

ARTICLE · 15 MAY 2018

FDA Issues Draft Guidance On Devices With Multiple Functions

Ropes & Gray LLP
Ropes & Gray LLP
Contributor
Ropes & Gray LLP

Ropes & Gray LLP

Ropes & Gray is one of the world’s most respected law firms, with offices in key business and...

View firm profile
Explore more from Ropes & Gray LLP

On April 27, 2018, FDA issued draft guidance on the regulation of devices with multiple functions.

United StatesFood, Drugs, Healthcare, Life Sciences

On April 27, 2018, FDA issued draft guidance on the regulation of devices with multiple functions. The draft guidance implements a requirement of the 21st Century Cures Act (Cures Act), signed into law on December 13, 2016, prohibiting FDA from directly regulating non-"device" software functions in digital health products. FDA did not limit the scope of the draft guidance to cover only the Cures Act mandate, however. Instead, the draft guidance addresses any type of product that includes both device and other functions, regardless of whether those functions involve software. Therefore, any manufacturer of a product that includes both FDA-regulated device functions and non-FDA-regulated functions should be familiar with the draft guidance.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from